1. Home
  2. BPMC vs VVV Comparison

BPMC vs VVV Comparison

Compare BPMC & VVV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BPMC
  • VVV
  • Stock Information
  • Founded
  • BPMC 2008
  • VVV 1866
  • Country
  • BPMC United States
  • VVV United States
  • Employees
  • BPMC N/A
  • VVV N/A
  • Industry
  • BPMC Biotechnology: Pharmaceutical Preparations
  • VVV Major Chemicals
  • Sector
  • BPMC Health Care
  • VVV Industrials
  • Exchange
  • BPMC Nasdaq
  • VVV Nasdaq
  • Market Cap
  • BPMC 5.8B
  • VVV 4.7B
  • IPO Year
  • BPMC 2015
  • VVV 2016
  • Fundamental
  • Price
  • BPMC $99.85
  • VVV $33.66
  • Analyst Decision
  • BPMC Buy
  • VVV Buy
  • Analyst Count
  • BPMC 21
  • VVV 11
  • Target Price
  • BPMC $124.05
  • VVV $42.91
  • AVG Volume (30 Days)
  • BPMC 1.0M
  • VVV 1.7M
  • Earning Date
  • BPMC 05-01-2025
  • VVV 05-08-2025
  • Dividend Yield
  • BPMC N/A
  • VVV N/A
  • EPS Growth
  • BPMC N/A
  • VVV 56.15
  • EPS
  • BPMC N/A
  • VVV 2.05
  • Revenue
  • BPMC $562,121,000.00
  • VVV $1,674,400,000.00
  • Revenue This Year
  • BPMC $44.85
  • VVV $9.14
  • Revenue Next Year
  • BPMC $32.06
  • VVV $14.43
  • P/E Ratio
  • BPMC N/A
  • VVV $16.57
  • Revenue Growth
  • BPMC 99.19
  • VVV 9.56
  • 52 Week Low
  • BPMC $73.04
  • VVV $31.02
  • 52 Week High
  • BPMC $121.90
  • VVV $48.27
  • Technical
  • Relative Strength Index (RSI)
  • BPMC 65.95
  • VVV 45.17
  • Support Level
  • BPMC $97.91
  • VVV $31.59
  • Resistance Level
  • BPMC $104.86
  • VVV $35.17
  • Average True Range (ATR)
  • BPMC 3.74
  • VVV 1.04
  • MACD
  • BPMC 1.50
  • VVV 0.05
  • Stochastic Oscillator
  • BPMC 83.26
  • VVV 56.42

About BPMC Blueprint Medicines Corporation

Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer.

About VVV Valvoline Inc.

Valvoline Inc produces, markets, and sells automotive maintenance products, particularly lubricants, to retail outlets installers, and customers. The company offers various products such as engine oil, heavy-duty engine oil, motorcycle oil, grease and brake fluid, and others. Geographically, the majority of the revenue is generated from the United States of America.

Share on Social Networks: